Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Comparison of the Ulcerative Colitis Disease Activity Index between the... | Download Table
Guidelines for the management of ulcerative colitis in the adult population (update)
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
New approaches in the follow-up of patients suffering from inflammatory bowel diseases
![PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3487ab107b3dfb52cb7dc2f7872fa75c27538395/5-Table4-1.png "PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar")
PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar
Inflammatory Bowel Disease | Clinical Gate
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set - Clinical Gastroenterology and Hepatology
Summary of activity indices used for ulcerative colitis | Download Table
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus - Vuitton - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study | BMJ Open Gastroenterology
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts - The American Journal of Pathology
Metabolites | Free Full-Text | Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis | HTML
Disease activity index (Schroeder and colleagues 14 ) | Download Table
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Cochrane
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions - Clinical Gastroenterology and Hepatology
UC-Disease Activity Index | Download Table
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study | Gut
